| Q90529323 | A Non-smoking Woman with Anti-phospholipid Antibodies Proved to Have Thromboangiitis Obliterans |
| Q37318783 | Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome |
| Q33491163 | Antiphospholipid antibodies in paediatrics |
| Q40559210 | Antiphospholipid antibodies. A marker for thrombosis and recurrent abortion |
| Q72611389 | Antiphospholipid syndrome |
| Q33565857 | Buerger's disease and antiphospholipid syndrome |
| Q73591829 | Histological appearance of the intra-osseous vessels of the femoral head in aseptic osteonecrosis of the hip, with or without antiphospholipid antibodies |
| Q33564078 | Inhibitory effects of anticardiolipin antibodies on lymphocyte proliferation and neutrophil phagocytosis. |
| Q37239201 | Non-nuclear staining of thick tissue sections |
| Q39619022 | Prospective comparative study of computer programs used for management of warfarin |
| Q33393937 | The 'antiphospholipid syndrome' and the 'lupus anticoagulant'. |
| Q71992286 | Treatment of the antiphospholipid syndrome |
| Q33566329 | Vasculitis in patients with systemic sclerosis and severe digital ischaemia requiring amputation |
| Q39619044 | Vasculopathy and antiphospholipid antibodies in systemic lupus |